The global Next-Generation Sequencing eDNA Biomonitoring market size is predicted to grow from US$ 23.3 million in 2024 to US$ 37.8 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030.
Next-generation sequencing technology, also known as high-throughput sequencing technology or new generation sequencing technology, can split DNA samples into thousands of tiny fragments, and quickly read them through high-throughput sequencers, and finally splice out a complete DNA sequence. This technology has the advantages of high throughput, low cost and short sequencing cycle, and shows extremely high detection accuracy and sensitivity in genome sequencing and genome monitoring.
High-throughput sequencing technology (i.e., next-generation sequencing technology) has the advantages of high throughput, low cost, and short sequencing cycle, and shows extremely high detection accuracy and sensitivity in genome sequencing and genome monitoring. These technological advances have made DNA biomonitoring more efficient and accurate, thereby driving the growth of the market. On the other hand, with the development of bioinformatics, the ability to analyze and interpret sequencing data is also constantly improving. This helps to extract valuable information from massive sequencing data and provide more accurate data support for environmental monitoring, disease diagnosis, etc.
With the continuous improvement of people's awareness of environmental protection, the demand for monitoring environmental DNA (eDNA) is also increasing. By monitoring DNA in the environment, we can understand the health of the ecosystem and promptly detect and respond to potential ecological problems. In the medical field, DNA sequencing technology is also widely used in disease diagnosis and prevention. By sequencing and analyzing individual genomes, the risk of individual illness can be predicted, providing strong support for early prevention and treatment of diseases. This demand has also driven the development of the next-generation sequencing environmental DNA biomonitoring market.
Although next-generation sequencing technology has made significant progress, there are still some technical challenges and limitations. For example, the accuracy and sensitivity of sequencing need to be further improved to better meet the needs of environmental monitoring and disease diagnosis. The amount of data generated by sequencing is huge, and contains a lot of redundant and erroneous information. How to extract valuable information from massive data is a technical problem currently faced. In addition, data analysis also requires professional knowledge and skills, which increases the complexity and cost of the operation.
In addition, although the cost of next-generation sequencing technology has been greatly reduced, it is still a considerable expense for some small laboratories or research institutions. The high cost of sequencing limits the widespread application and promotion of the technology.
Although the next-generation sequencing environmental DNA biomonitoring technology has broad application prospects, the current market awareness of it is not high. Some potential customers may take a wait-and-see attitude towards this new technology, waiting for it to further mature and popularize. Customers in different fields and industries have different acceptance of technology. Some fields may prefer to adopt traditional monitoring methods and technologies, and are less willing to try new sequencing technologies.
The 鈥淣ext-Generation Sequencing eDNA Biomonitoring Industry Forecast鈥� looks at past sales and reviews total world Next-Generation Sequencing eDNA Biomonitoring sales in 2023, providing a comprehensive analysis by region and market sector of projected Next-Generation Sequencing eDNA Biomonitoring sales for 2024 through 2030. With Next-Generation Sequencing eDNA Biomonitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Sequencing eDNA Biomonitoring industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Sequencing eDNA Biomonitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next-Generation Sequencing eDNA Biomonitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Next-Generation Sequencing eDNA Biomonitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Sequencing eDNA Biomonitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Sequencing eDNA Biomonitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Sequencing eDNA Biomonitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Segmentation by Application:
Water
Soil
Air
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina, Inc
Stantec
Eurofins Genomics
Spygen
ID-Gene Ecordiagnostics
EnviroDNA
eDNAtec
Genidaqs
NatureMetrics
Jonah Ventures
Sinsoma GmbH
SimplexDNA
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size 2019-2030
2.1.2 Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Next-Generation Sequencing eDNA Biomonitoring by Country/Region, 2019, 2023 & 2030
2.2 Next-Generation Sequencing eDNA Biomonitoring Segment by Type
2.2.1 Targeted Sequencing & Resequencing
2.2.2 Whole Genome Sequencing
2.2.3 Whole Exome Sequencing
2.3 Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Type
2.3.1 Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Next-Generation Sequencing eDNA Biomonitoring Segment by Application
2.4.1 Water
2.4.2 Soil
2.4.3 Air
2.4.4 Others
2.5 Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Application
2.5.1 Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Player
3.1 Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Player (2019-2024)
3.1.2 Global Next-Generation Sequencing eDNA Biomonitoring Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Next-Generation Sequencing eDNA Biomonitoring Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Next-Generation Sequencing eDNA Biomonitoring by Region
4.1 Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Region (2019-2024)
4.2 Global Next-Generation Sequencing eDNA Biomonitoring Annual Revenue by Country/Region (2019-2024)
4.3 Americas Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size Growth (2019-2024)
4.4 APAC Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size Growth (2019-2024)
4.5 Europe Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Country (2019-2024)
5.2 Americas Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Type (2019-2024)
5.3 Americas Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Region (2019-2024)
6.2 APAC Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Type (2019-2024)
6.3 APAC Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Country (2019-2024)
7.2 Europe Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Type (2019-2024)
7.3 Europe Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring by Region (2019-2024)
8.2 Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Forecast
10.1 Global Next-Generation Sequencing eDNA Biomonitoring Forecast by Region (2025-2030)
10.1.1 Global Next-Generation Sequencing eDNA Biomonitoring Forecast by Region (2025-2030)
10.1.2 Americas Next-Generation Sequencing eDNA Biomonitoring Forecast
10.1.3 APAC Next-Generation Sequencing eDNA Biomonitoring Forecast
10.1.4 Europe Next-Generation Sequencing eDNA Biomonitoring Forecast
10.1.5 Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring Forecast
10.2 Americas Next-Generation Sequencing eDNA Biomonitoring Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.2.2 Canada 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.2.3 Mexico 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.2.4 Brazil 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.3 APAC Next-Generation Sequencing eDNA Biomonitoring Forecast by Region (2025-2030)
10.3.1 China Next-Generation Sequencing eDNA Biomonitoring 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.3.3 Korea 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.3.4 Southeast Asia 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.3.5 India 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.3.6 Australia 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.4 Europe Next-Generation Sequencing eDNA Biomonitoring Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.4.2 France 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.4.3 UK 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.4.4 Italy 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.4.5 Russia 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.5 Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.5.2 South Africa 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.5.3 Israel 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.5.4 Turkey 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
10.6 Global Next-Generation Sequencing eDNA Biomonitoring Forecast by Type (2025-2030)
10.7 Global Next-Generation Sequencing eDNA Biomonitoring Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Next-Generation Sequencing eDNA Biomonitoring Forecast
11 Key Players Analysis
11.1 Illumina, Inc
11.1.1 Illumina, Inc Company Information
11.1.2 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.1.3 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Illumina, Inc Main Business Overview
11.1.5 Illumina, Inc Latest Developments
11.2 Stantec
11.2.1 Stantec Company Information
11.2.2 Stantec Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.2.3 Stantec Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Stantec Main Business Overview
11.2.5 Stantec Latest Developments
11.3 Eurofins Genomics
11.3.1 Eurofins Genomics Company Information
11.3.2 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.3.3 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Eurofins Genomics Main Business Overview
11.3.5 Eurofins Genomics Latest Developments
11.4 Spygen
11.4.1 Spygen Company Information
11.4.2 Spygen Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.4.3 Spygen Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Spygen Main Business Overview
11.4.5 Spygen Latest Developments
11.5 ID-Gene Ecordiagnostics
11.5.1 ID-Gene Ecordiagnostics Company Information
11.5.2 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.5.3 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 ID-Gene Ecordiagnostics Main Business Overview
11.5.5 ID-Gene Ecordiagnostics Latest Developments
11.6 EnviroDNA
11.6.1 EnviroDNA Company Information
11.6.2 EnviroDNA Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.6.3 EnviroDNA Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 EnviroDNA Main Business Overview
11.6.5 EnviroDNA Latest Developments
11.7 eDNAtec
11.7.1 eDNAtec Company Information
11.7.2 eDNAtec Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.7.3 eDNAtec Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 eDNAtec Main Business Overview
11.7.5 eDNAtec Latest Developments
11.8 Genidaqs
11.8.1 Genidaqs Company Information
11.8.2 Genidaqs Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.8.3 Genidaqs Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Genidaqs Main Business Overview
11.8.5 Genidaqs Latest Developments
11.9 NatureMetrics
11.9.1 NatureMetrics Company Information
11.9.2 NatureMetrics Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.9.3 NatureMetrics Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 NatureMetrics Main Business Overview
11.9.5 NatureMetrics Latest Developments
11.10 Jonah Ventures
11.10.1 Jonah Ventures Company Information
11.10.2 Jonah Ventures Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.10.3 Jonah Ventures Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Jonah Ventures Main Business Overview
11.10.5 Jonah Ventures Latest Developments
11.11 Sinsoma GmbH
11.11.1 Sinsoma GmbH Company Information
11.11.2 Sinsoma GmbH Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.11.3 Sinsoma GmbH Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Sinsoma GmbH Main Business Overview
11.11.5 Sinsoma GmbH Latest Developments
11.12 SimplexDNA
11.12.1 SimplexDNA Company Information
11.12.2 SimplexDNA Next-Generation Sequencing eDNA Biomonitoring Product Offered
11.12.3 SimplexDNA Next-Generation Sequencing eDNA Biomonitoring Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 SimplexDNA Main Business Overview
11.12.5 SimplexDNA Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.